home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Novel Immunotherapeutics Summit

 
  August 12, 2014  
     
 
GTCbio, San Diego, CA
January 29-30, 2015


The Summit will begin with a plenary keynote session, and then break into four concurrent conferences, all of which will talk about complementary areas of the latest breakthroughs in the immunology field:

13th Cytokines & Inflammation
This meeting provides a forum for researchers to discuss the latest advances in targeting cytokines and chemokines for therapeutic interventions, cytokines and metabolism, and cytokines signaling pathways.

7th Immunotherapeutics & Immunomonitoring
Leading experts will cover recent advances in immunotherapy and how they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. 

3rd Immunogenicity and Immunotoxicity
Delegates will learn about ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins.

2nd Innate Immunity
Come learn about discoveries in toll like receptors, inflammasome reactions, the role of the microbiome and non-pathogenic bacteria, and many more.
 
 
Organized by: GTCbio
Invited Speakers:

Jules Hoffman
Nobel Prize Laureate
CNRS, University of Strasbourg

 

Joost J. Oppenheim
Chief
Laboratory of Molecular Immunoregulation
National Cancer Institute

 

Francisco Leon
Vice President
Translational Medicine, Immunology Development 
Janssen R&D (Pharmaceutical Companies of Johnson & Johnson) 
 
Deadline for Abstracts: 2014-12-29
 
Registration: https://www.gtcbio.com/register/immunotherapeutics-summit
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.